These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21838517)

  • 1. The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series.
    Kerr C; Holahan T; Milch R
    J Palliat Med; 2011 Sep; 14(9):1074-7. PubMed ID: 21838517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
    Patil S; Anitescu M
    Pain Med; 2012 Feb; 13(2):263-9. PubMed ID: 21939497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
    Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M; White N; Jean CS; Zempsky WT; Steven K
    J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care.
    Salas S; Frasca M; Planchet-Barraud B; Burucoa B; Pascal M; Lapiana JM; Hermet R; Castany C; Ravallec F; Loundou A; Auquier P; Duffaud F; Baumstarck K
    J Palliat Med; 2012 Mar; 15(3):287-93. PubMed ID: 22335487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subanesthetic ketamine for cancer pain: by insisting on level I/II evidence, do we risk throwing the baby out with the bath water?
    Jackson K; Ashby M; Goodchild C
    J Pain Symptom Manage; 2005 Apr; 29(4):328-30. PubMed ID: 15857732
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient.
    Clark JL; Kalan GE
    J Pain Symptom Manage; 1995 May; 10(4):310-4. PubMed ID: 7541437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Waldfogel JM; Nesbit S; Cohen SP; Dy SM
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ketamine infusion therapy for refractory neuralgia in spinal disease: report of two cases].
    Matsuda W; Matsumura A; Enomoto T; Nose T; Suga A; Miyabe M; Toyooka H
    No Shinkei Geka; 1999 Feb; 27(2):195-200. PubMed ID: 10065454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Subanesthetic Ketamine Bolus and Infusion for Opioid Refractory Cancer Pain.
    Forth N; Nguyen M; Grech A
    J Palliat Med; 2022 Jul; 25(7):1161-1165. PubMed ID: 35085456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
    Fine PG
    J Pain Symptom Manage; 1999 Apr; 17(4):296-300. PubMed ID: 10203883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Subanesthetic Ketamine be Considered When Managing Opioid Refractory Cancer Pain?
    Poon P; Bell RF; Good P
    J Pain Symptom Manage; 2024 Aug; 68(2):e146-e151. PubMed ID: 38729533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.
    Fitzgibbon EJ; Viola R
    J Palliat Med; 2005 Feb; 8(1):49-57. PubMed ID: 15662173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.